Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05929469 · ClinicalTrials.gov registry record · NA
PATH to Health: An Exploration of Digital Behavioral Weight Loss Approaches
A NA study of Obesity and Overweight, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- NA
- Development phase
- 99
- Enrollment target
- 1
- Study location
NCT05929469: Completed NA study of Obesity and Overweight, sponsored by University of North Carolina, Chapel Hill.
NCT05929469 is a NA study of Obesity and Overweight that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 99 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05929469, a NA study of Obesity and Overweight, has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- NA
- Development phase
- 99 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this initial pilot and feasibility study is to test different digital, behavioral weight loss approaches, with or without human support, using a sequential, multiple assignment, randomized trial (SMART) design. All participants in this pilot trial will receive a 3-month mobile health (mHealth) program. The dose of human support will vary by first- and second-line randomizations. The feasibility, acceptability, and preliminary outcomes for each of the treatment sequences will be assessed.
Primary Outcome
The rate of early response will be calculated as the number of individuals deemed "early responders" divided by the total number of participants randomized.
Conditions Studied
Interventions
- BEHAVIORAL Counseling
- BEHAVIORAL App
- BEHAVIORAL Fully Automated Kick-Off
- BEHAVIORAL Human-Enhanced Kick-Off
- BEHAVIORAL Check-In
Study Locations (1)
North Carolina
- University of North Carolina at Chapel Hill - Chapel Hill
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 99 participants |
| Start Date | 2023-10-02 |
| Est. Completion | 2024-04-25 |
| Phase | NA |
What the finished NCT05929469 record still lists
NCT05929469 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 99 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (88% lower).
The record links to 3 conditions, with Obesity appearing as the primary indexed condition, and to 5 interventions - of which Counseling is the first listed.
NCT05929469 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT05929469 about?
NCT05929469 is a clinical study titled "PATH to Health: An Exploration of Digital Behavioral Weight Loss Approaches". The purpose of this initial pilot and feasibility study is to test different digital, behavioral weight loss approaches, with or without human support, using a sequential, multiple assignment, randomized trial (SMART) design. All participants in this pilot trial will receive a 3-month mobile health ...
What is the current status of trial NCT05929469?
This trial is currently completed. It is a NA study. The enrollment target is 99 participants. The study started on 2023-10-02. Estimated completion is 2024-04-25.
What conditions does trial NCT05929469 study?
This clinical trial studies the following conditions: Obesity, Overweight, Overweight and Obesity.
What interventions are being tested in trial NCT05929469?
The interventions under investigation include: Counseling (BEHAVIORAL), App (BEHAVIORAL), Fully Automated Kick-Off (BEHAVIORAL), Human-Enhanced Kick-Off (BEHAVIORAL), Check-In (BEHAVIORAL).
Who is sponsoring clinical trial NCT05929469?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05929469 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05929469's enrollment target sits among peer trials
99 500th of 1053 higher than 553 of 1,053 other Obesity trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Testing an Integrated PTSD and Weight Management Intervention: A Hybrid Type 1 Trial
RECRUITING · NA
-
Tai Chi as a Novel Strategy to Increase Physical Activity Among Adults Pursuing Metabolic and Bariatric Surgery
RECRUITING · NA
-
Mechanistic and Clinical Outcomes of a Surgical Innovation Aimed at Minimizing GERD Associated With VSG (INNOVATE-VSG)
RECRUITING · NA
-
SMARTer Weight Loss Management
RECRUITING · NA
-
HealthyTogether: RCT of a Dyadic Weight Management Intervention
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03965234 · 99 participants · Phase 1
Pulmonary Suffusion in Controlling Minimal Residual Disease in Patients With Sarcoma or Colorectal Metastases
- NCT04022616 · 99 participants
Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients
- NCT04042844 · 99 participants · Phase 2
A Single Dose of BRTX 100 for Patients With Chronic Lumbar Disc Disease (cLDD)
- NCT04143724 · 99 participants · Phase 2
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI